Rxsight Inc
RxSight, Inc., a commercial-stage medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight Light Adjustable Lens (LAL), an intraocular lens made of photosensitive material that changes shape in response to specific patterns of ultraviolet, which can be adjusted to improve uncorrected visual acuity; and RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. RxSight, Inc. was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. The company was incorporated in 1997 and is headquartered in Aliso Viejo, California.
- Chief executive
- Mr. Aziz Mottiwala M.B.A.
- Employees
- 461
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- US
- IPO date
- 2021-07-30
Profile observed 2026-09-08 03:08:06.280846+00 via eodhd.
Forecasts are available for Rxsight Inc's listed securities
A corporation provides context; forecasts attach to the exact market security and forecast target. Choose a related security below.
Identifiers & semantic identity
External identifiers, stable Library identity, and semantic-web assertions describe the same governed entity.
- iPulse entity ID
- fundsubj_fbb2f660-bab8-5ebf-8743-d95754cbed00
- Wikidata ID
- No verified external match
- Google Knowledge Graph MID
- No verified external match
Relationship graph
2D · draggableThe blue forecastable node can receive forecast targets. Green context nodes explain who issues, owns, or hosts it.